Literature DB >> 6297917

Prolactin receptors in human breast cancer.

J Bonneterre, J P Peyrat, B Vandewalle, R Beuscart, M C Vie, P Cappelaere.   

Abstract

Prolactin receptors have been measured in 92 human breast carcinomas. Both free and total receptors (after desaturation by MgCl2) have been looked for. Free receptors have been found in 46% of the cases, total receptors in 72%. Specific binding ranges from 0.8 to 8.0%. No correlation could be found between prolactin receptors and age, weight, menopausal status and pathological features (differentiation, histoprognostic grading, cellular density). A highly significant correlation has been found between prolactin receptors on the one hand and estradiol and progesterone receptors on the other.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6297917     DOI: 10.1016/0277-5379(82)90097-9

Source DB:  PubMed          Journal:  Eur J Cancer Clin Oncol        ISSN: 0277-5379


  5 in total

1.  Activation of raf-1, MEK, and MAP kinase in prolactin responsive mammary cells.

Authors:  R Das; B K Vonderhaar
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

2.  Characterization of prolactin receptors in human breast cancer.

Authors:  J P Peyrat; J Djiane; P A Kelly; B Vandewalle; J Bonneterre; A Demaille
Journal:  Breast Cancer Res Treat       Date:  1984       Impact factor: 4.872

Review 3.  Prolactin and breast cancer etiology: an epidemiologic perspective.

Authors:  Shelley S Tworoger; Susan E Hankinson
Journal:  J Mammary Gland Biol Neoplasia       Date:  2008-02-02       Impact factor: 2.673

4.  Characterization of ductal and lobular breast carcinomas using novel prolactin receptor isoform specific antibodies.

Authors:  Erika Ginsburg; Stefanie Alexander; Sarah Lieber; Sarah Tarplin; Luwanda Jenkins; Linda Pang; Christopher D Heger; Paul Goldsmith; Barbara K Vonderhaar
Journal:  BMC Cancer       Date:  2010-12-13       Impact factor: 4.430

5.  Expression and prognostic significance of lysozyme in male breast cancer.

Authors:  Carlos Serra; Francisco Vizoso; Lorena Alonso; Juan C Rodríguez; Luis O González; María Fernández; María L Lamelas; Luis M Sánchez; José L García-Muñiz; Aniceto Baltasar; Justo Medrano
Journal:  Breast Cancer Res       Date:  2002-08-27       Impact factor: 6.466

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.